March 11 (Reuters) - Regenxbio said on Wednesday that interim data from a early-to-mid stage study of its experimental gene ...
This 7-minute dumbbell routine builds real muscle after 60. A 35-year fitness expert shares the only 4 exercises you need to ...
NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...
Modern technology has transformed the abdominal massage belt far beyond simple vibrating mechanisms. Today’s devices ...
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...
Parkinson's disease is the fastest growing neurological disorder, with more than 10 million cases worldwide. Up to 150,000 ...
Hypertrophic scarring affects a large proportion of patients following burns, trauma, or surgery and arises from prolonged fibroblast hyperactivity and excessive extracellular matrix accumulation.
A synthetic tripeptide inspired by snake venom is opening new investigative routes into cellular signalling and structural ...
Podiatrists break down the latest findings.
Neurocrine Biosciences has rebounded 60% since April 2025, driven by robust Ingrezza sales and Crenessity's uncontested launch. Read why NBIX stock is a hold.
It often loses out to other rooms in the house regarding smart home and high-tech upgrades, but there are lots of ways to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results